Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 2/20 | 0.43 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PRNP | P04156 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18926922 | 0.86 | SLC6A3 (0.45) | CDC14BCDC14AKMT2AKDM4EALDH1A1 | |
| SCHEMBL22376432 | 0.81 | ALOX5 (0.44) | CDC14BCDC14AKMT2AKDM4EALDH1A1 | |
| SCHEMBL19585040 | 0.81 | ALOX5 (0.55) | CDC14BCDC14AALOX5 | |
| SCHEMBL18854814 | 0.81 | ALOX5 (0.55) | KDM4EPOLBALOX5CYP3A4CYP2C9 | |
| SCHEMBL24862831 | 0.78 | CDC14B (0.40) | CDC14BCDC14AKMT2AKDM4EALDH1A1 | |
| SCHEMBL25853300 | 0.78 | CDC14B (0.43) | CDC14BCDC14AKDM4EALDH1A1ALOX5 | |
| SCHEMBL18382951 | 0.77 | CDC14B (0.52) | CDC14BCDC14AKMT2AKDM4EALDH1A1 | |
| SCHEMBL30152085 | 0.77 | CDC14B (0.52) | CDC14BCDC14AKMT2AKDM4EALDH1A1 | |
| SCHEMBL18165289 | 0.77 | ALOX5 (0.55) | KMT2AKDM4EALDH1A1GLAALOX5 | |
| SCHEMBL24896118 | 0.76 | CDC14B (0.44) | CDC14BCDC14AKMT2AKDM4EALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | SFC CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | SFC CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| EP-4116297-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC Co., Ltd. (KR) | 2023-01-11 | — | — | EP | disclosed |
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| EP-3176158-A2 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETERO RING | SFC Co., Ltd. (KR) | 2017-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222155-A1 | CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING | CCNE2, INF2, AFF4 | CDC14B 1760/4885CDC14A 1537/4885KMT2A 1582/4885 |
| US-11683980-B2 | Condensed fluorene derivative comprising heterocyclic ring | CCNE2, INF2, AFF4 | CDC14B 1760/4885CDC14A 1537/4885KMT2A 1582/4885 |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | EML4, SLC18A2, TYR | CDC14B 3208/4885CDC14A 3551/4885KMT2A 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.